Mason Street Advisors, LLC Medpace Holdings, Inc. Transaction History

Mason Street Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $1.94 Million - $2.48 Million	-14,711 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$109.38 - $149.19 $13,016 - $17,753	119 Added 0.82%	14,711 $2.05 Million
Q3 2020 Nov 13, 2020	BUY	$92.95 - $130.61 $418,182 - $587,614	4,499 Added 44.58%	14,592 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $37,784 - $53,102	555 Added 5.82%	10,093 $939,000
Q4 2019 Feb 19, 2020	BUY	$70.08 - $84.64 $22,846 - $27,592	326 Added 3.54%	9,538 $802,000

Q3 2019 Nov 05, 2019	BUY	$62.38 - $85.89 $30,191 - $41,570	484 Added 5.55%	9,212 $774,000
Q2 2019 Aug 12, 2019	BUY	$53.64 - $65.42 $19,364 - $23,616	361 Added 4.31%	8,728 $571,000
Q1 2019 May 07, 2019	BUY	$49.38 - $70.58 $16,789 - $23,997	340 Added 4.24%	8,367 $493,000
Q4 2018 Feb 13, 2019	BUY	$46.97 - $63.98 $377,028 - $513,567	8,027 New	8,027 $425,000

622

25.1M

154K

117K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.